Clinical outcomes and molecular profile of patients with Carmi syndrome: A systematic review and evidence quality assessment

Systematic review of 100 Carmi syndrome patients reveals 74.5% mortality despite surgical intervention for pyloric atresia, with survival strongly predicted by integrin α6β4 expression patterns. Immunofluorescence mapping and genetic testing can identify the 25% with nonlethal phenotypes who may benefit from surgical repair.